Multiple myeloma beneficially alters the TiME for survival and progression, such as by increasing the number of regulatory T cells, exhausted CD8 T cells, and myeloid-derived suppressor cells, and decreasing that of cytotoxic CD8 T cells (4–6). The gene discussed is CD8A; the disease is plasma cell myeloma.